2 Winning Biotech Stocks to Buy for the Fourth Quarter

This post was originally published on this site


The global biotechnology market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Spurred by COVID-19, the VanEck Vectors Biotech ETF (BBH) has gained 63.4% over the past two years, surpassing the broader SPDR S&P 500 ETF Trust’s (SPY) 48.1% gain.

Therefore, fundamentally sound biotech stocks Harmony Biosciences Holdings, Inc. (HRMY) and Dynavax Technologies Corporation (DVAX), which are currently trading above their 50-day and 200-day moving averages, could be solid bets.

Continue reading on StockNews

Add Comment